King’s Brief Interstitial Lung Disease (K-BILD) questionnaire: content relevance in progressive fibrosing ILD (PF-ILD)

S. Birring (London, United Kingdom), D. Bushnell (Bethesda, MD, United States of America), K. Cutts (Bethesda, MD, United States of America), M. Baldwin (Ingelheim am Rhein, Germany), K. Rohr (Ingelheim am Rhein, Germany), N. Male (Ingelheim am Rhein, Germany)

Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Session: Natural history and management of interstitial lung diseases of known cause
Session type: E-poster session
Number: 1813
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Birring (London, United Kingdom), D. Bushnell (Bethesda, MD, United States of America), K. Cutts (Bethesda, MD, United States of America), M. Baldwin (Ingelheim am Rhein, Germany), K. Rohr (Ingelheim am Rhein, Germany), N. Male (Ingelheim am Rhein, Germany). King’s Brief Interstitial Lung Disease (K-BILD) questionnaire: content relevance in progressive fibrosing ILD (PF-ILD). 1813

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Translation and validation of the King's brief interstitial lung disease (K-BILD) questionnaire in French, Italian and Dutch
Source: International Congress 2014 – ILDs 2
Year: 2014

King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference
Source: Eur Respir J, 54 (3) 1900281; 10.1183/13993003.00281-2019
Year: 2019



Response of the King’s brief interstitial lung disease (KBILD) questionnaire to pulmonary rehabilitation (PR)
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015


The King’s brief interstitial lung disease (K-BILD) questionnaire; an updated minimal important difference
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Validation of the King’s Brief Interstitial Lung Disease questionnaire in Danish
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019


Translation and preliminary validation of the KBILD QOL questionnaire to Spanish
Source: International Congress 2014 – ILDs 6
Year: 2014

Comparison of changes of the King’s brief interstitial lung disease questionnaire (K-BILD) with other health status measures
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016

Depression and anxiety in pulmonary fibrosis: A pilot study
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


A comparison of two scoring methods for the King’s sarcoidosis questionnaire
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015


The validation of the Severe Asthma Questionnaire (SAQ).
Source: International Congress 2018 – Asthma management
Year: 2018



Psychometric validation of the Visual Simplified Respiratory Questionnaire (VSRQ) in France for chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005

Inmunosuppresor therapy effectivness in Interstitial Lung Disease (ILD) associated Connective Tisuue Disease(CTD).
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017


Evaluation of Dyspnea Questionnaires in Patients with Idiopathic Pulmonary Fibrosis (IPF).
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021


Hypersentivity pneumonitis in an Interstitial Lung Disease Unit, 5 years’ experience
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020


Health Related Quality of Life (HRQL) in sarcoidosis – Sarcoidosis Health Questionnaire (SHQ) and correlation with clinical course of sarcoidosis – follow up study
Source: Eur Respir J 2006; 28: Suppl. 50, 95s
Year: 2006

The Hospital Anxiety and Depression Scale (HADS) in Bronchiectasis: Response to pulmonary rehabilitation (PR) and Minimum Clinically Important Difference (MCID)
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019

Unclassifiable Interstitial Lung Disease (ILD). Why?
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Correlations between Lung Clearance Index (LCI) measurements and spirometry in Chronic Obstructive Pulmonary Disease (COPD).
Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease
Year: 2019